FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for Hydrochlorothiazide submitted by Aurobindo Pharma Limited under an Abbreviated New Drug Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Hypertension

Drugs mentioned

• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)